Tirzepatide Kwikpen is a once-weekly injection device containing tirzepatide, a dual GIP and GLP-1 receptor agonist used to treat adults with type 2 diabetes as well as for long-term weight management in those with obesity or overweight accompanied by weight-related health issues. Tirzepatide is also approved for addressing moderate-to-severe obstructive sleep apnea in adults who have obesity. It aids in controlling blood sugar levels and appetite, and is administered using an easy-to-use autoinjector pen for added convenience. This medication provides benefits for both glycemic control and weight reduction, making it an innovative option in diabetes and obesity care.